<div><h4 class="widget-title widgettitle">All the Rest</h4>
<a href="https://emcrit.org/pulmcrit/pjp/" title="IBCC chapter &amp; cast &#8211; Pneumocystis Jirovicii Pneumonia" class="alignleft"><img width="150" height="150" src="https://i2.wp.com/emcrit.org/wp-content/uploads/2020/06/pjptop-scaled.jpg?resize=150%2C150&amp;ssl=1" class="" alt=""></a><h2><a href="https://emcrit.org/pulmcrit/pjp/" title="IBCC chapter &amp; cast &#8211; Pneumocystis Jirovicii Pneumonia">IBCC chapter &amp; cast &#8211; Pneumocystis Jirovicii Pneumonia</a></h2><p>Pneumocystic Jirovicii Pneumonia (previously Pneumocystic Carinii Pneumonia) remains an important opportunistic infection in critical care.&#160; Improved treatment for HIV has reduced the frequency of PJP due to AIDS, but meanwhile the development of increasingly sophisticated immunosuppressive regimens for other patient populations has increased the incidence of non-HIV PJP.&#160; New diagnostic tests are improving our ability [&#8230;]</p>
<a href="https://emcrit.org/pulmcrit/recovery/" title="PulmCrit &#8211; Dexamethasone &amp; COVID &#8211; a study in immunopathology, evidence-based medicine, and ourselves" class="alignleft"><img width="150" height="150" src="https://i0.wp.com/emcrit.org/wp-content/uploads/2020/06/dexaimage-scaled.jpg?resize=150%2C150&amp;ssl=1" class="" alt=""></a><h2><a href="https://emcrit.org/pulmcrit/recovery/" title="PulmCrit &#8211; Dexamethasone &amp; COVID &#8211; a study in immunopathology, evidence-based medicine, and ourselves">PulmCrit &#8211; Dexamethasone &amp; COVID &#8211; a study in immunopathology, evidence-based medicine, and ourselves</a></h2><p>Early in the COVID epidemic, it became clear that the virus often causes a cytokine storm, leading to immunopathological organ damage.&#160;&#160; The first major study to suggest benefit from steroid in COVID was a retrospective study by Wang et al. released in early March, which found reduced mortality among COVID patients with ARDS who were [&#8230;]</p>
<a href="https://emcrit.org/pulmcrit/vcd/" title="IBCC chapter &amp; cast &#8211; Vocal cord dysfunction" class="alignleft"><img width="150" height="150" src="https://i0.wp.com/emcrit.org/wp-content/uploads/2017/01/vcdheader.jpg?resize=150%2C150&amp;ssl=1" class="" alt=""></a><h2><a href="https://emcrit.org/pulmcrit/vcd/" title="IBCC chapter &amp; cast &#8211; Vocal cord dysfunction">IBCC chapter &amp; cast &#8211; Vocal cord dysfunction</a></h2><p>Vocal cord dysfunction is a masquerader of life-threatening pathologies (most notably asthma and anatomic upper airway obstruction).&#160; Vocal cord dysfunction itself is not dangerous, but if not properly diagnosed it may lead to considerable iatrogenic harm (e.g. multiple unnecessary intubations for &#8220;asthma&#8221;).&#160; On the flip side, incorrect diagnosis of vocal cord dysfunction is also dangerous, [&#8230;]</p>
<a href="https://emcrit.org/pulmcrit/aspergillosis/" title="IBCC chapter &amp; cast &#8211; Invasive pulmonary aspergillosis" class="alignleft"><img width="150" height="150" src="https://i1.wp.com/emcrit.org/wp-content/uploads/2020/06/asptop.jpg?resize=150%2C150&amp;ssl=1" class="" alt=""></a><h2><a href="https://emcrit.org/pulmcrit/aspergillosis/" title="IBCC chapter &amp; cast &#8211; Invasive pulmonary aspergillosis">IBCC chapter &amp; cast &#8211; Invasive pulmonary aspergillosis</a></h2><p>Invasive pulmonary aspergillosis was traditionally conceptualized as a rare infection restricted to profoundly immunocompromised patients.&#160; However, over the past decade, it&#8217;s become increasingly clear that invasive aspergillosis can also occur as a nosocomial superinfection among patients who aren&#8217;t immunocompromised (especially following influenza).&#160; This opens a can of worms regarding how to sift out colonization versus [&#8230;]</p>
</div>